Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.